CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...
News Medical on MSN5d
First U.S. trial uses non-viral CRISPR to correct sickle cell mutationUCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback